172 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
or an employee benefit plan of that Party (including any trustee of such plan acting as trustee)) hereafter acquires beneficial ownership of securities
424B7
agf b2mkaaqsc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K
EX-99.1
h4uxaj32yuguohf31o
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-10.1
a91to7 dkgc5ns
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K/A
EX-99.1
3t7v87a70qbls2
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
ulfpcnjx1ri2avb1rpku
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-10.1
tuzd11234 vk1kp1dmc5
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
c5b25qeu
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am